EGA Annual Conference

Brussels Hilton Hotel
20-21 November 2001

---

Generic Medicines: Encouraging Competition
and Affordability
In Europe’s Healthscare Market

---

Tuesday 20 November (13:00-18:00)

Improving the Regulatory and Legal Framework
for Generic Competition

---

Opening Address by EU Commissioner Erkki Liikanen

Creating a Regulatory Environment Suitable for Generic Medicines

• Identifying Key Legal Hurdles in the Regulatory System for Generic Medicines: Carla Schoonderbeek (Partner in the lawfirm CMS Derks Star Busmann)
• Does the Commission Proposal Improve the Product Registration System for Generic Medicines? Susan De Stasio (Chair EGA Regulatory and Scientific Affairs Committee)
• Viewpoint of panel of experts from European Commission, EU and CEE Health Regulatory Agencies and European Parliament

Creating Competition in the EU Pharmaceutical Market

• How Generic Medicines Encourage Competition and Innovation: Stephen Schondelmeyer (University of Minnesota, USA)
• Does the Proposed EU Legislation Create the Right Environment for Generic Competition in the EU?: René Numan (Chair of EGA Health Economics Committee)
• Viewpoint of panel of experts from European Parliament, National Ministries and European Commission

Cocktail and Dinner Reception (19:00):

Overview of the EU Market

• Graham Lewis (IMS Health)

Competing in Established Markets

• UK and Europe: Steve Self (Merck Generics)

Have the EU's Emerging Generic Markets Taken off?

• France: Philippe Conquet (Droit et Pharmacie)
• Spain: Elisabeth Stampa (CEO CombinoPharm)
• Italy: Paolo Romagnoli (Aschimfarma)

Competing in the CEE Countries Before and After Accession

• Challenges for industry caused by accession: Gorazd Hladnik (Chair of EGA Accession Committee)
• Poland: Waldemar Roszkowski (Vice-President EGA and former President of Polfarmed)
• Hungary and Eastern Europe: View point of the market leader - Gedeon Richter

---

All pictures: © OPT

<< Back